Compare SRRK & LSTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRRK | LSTR |
|---|---|---|
| Founded | 2012 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trucking Freight/Courier Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 5.7B |
| IPO Year | 2018 | 1994 |
| Metric | SRRK | LSTR |
|---|---|---|
| Price | $41.57 | $169.69 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 18 | 18 |
| Target Price | $70.44 | ★ $187.69 |
| AVG Volume (30 Days) | ★ 1.8M | 265.9K |
| Earning Date | 11-13-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 1.04% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.16 |
| Revenue | N/A | ★ $4,743,760,000.00 |
| Revenue This Year | N/A | $17.36 |
| Revenue Next Year | $2,404.46 | $10.96 |
| P/E Ratio | ★ N/A | $146.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $27.07 | $121.12 |
| 52 Week High | $61.76 | $228.46 |
| Indicator | SRRK | LSTR |
|---|---|---|
| Relative Strength Index (RSI) | 30.05 | 46.44 |
| Support Level | $39.69 | $168.99 |
| Resistance Level | $48.59 | $175.14 |
| Average True Range (ATR) | 1.89 | 3.59 |
| MACD | -0.23 | 0.74 |
| Stochastic Oscillator | 14.72 | 40.46 |
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
Landstar System is an agent based asset-light third-party logistics provider focused on domestic truck brokerage. Historically, around half of its truck transportation freight is hauled by leased owner-operators with the remainder hauled by third-party broker-carriers. To a smaller degree, it offers intermodal, global air and ocean forwarding, and warehousing services. Landstar also runs a small business that offers insurance programs to captive owner-operators. It has a long history of industry-leading execution and operating profitability.